Social Class and Cardiovascular Risk Factors in Danish MenMØLLER, L; KRISTENSEN, T. S; HOLLNAGEL, G et al.Scandinavian journal of social medicine. 1991, Vol 19, Num 2, pp 116-126, issn 0300-8037Article

Surrogate markers for cardiovascular disease : Structural markersMANCINI, G. B; DAHLÖF, Bjorn; DIEZ, Javier et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 25, pp 22-30, issn 0009-7322, 9 p., SUPArticle

Surrogate markers for cardiovascular disease : Functional markersCOHN, Jay N; QUYYUMI, Arshed A; HOLLENBERG, Norman K et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 25, pp 31-46, issn 0009-7322, 16 p., SUPArticle

Cardiovascular manifestations of rheumatologic diseasesROMAN, Mary J; SALMON, Jane E.Circulation (New York, N.Y.). 2007, Vol 116, Num 20, pp 2346-2355, issn 0009-7322, 10 p.Article

Baseline ICAM-1 and VCAM-1 Are Increased in Initially Healthy Middle-Aged Men Who Develop Cardiovascular Disease During 6.6 Years of Follow-UpSCHMIDT, Caroline; HULTHE, Johannes; FAGERBERG, Bjorn et al.Angiology. 2009, Vol 60, Num 1, pp 108-114, issn 0003-3197, 7 p.Article

Adipocytokines in relation to cardiovascular diseaseVAN DE VOORDE, Johan; PAUWELS, Bart; BOYDENS, Charlotte et al.Metabolism, clinical and experimental. 2013, Vol 62, Num 11, pp 1513-1521, issn 0026-0495, 9 p.Article

Medication Adherence in Cardiovascular DiseaseBAROLETTI, Steven; DELL'ORFANO, Heather.Circulation (New York, N.Y.). 2010, Vol 121, Num 12, pp 1455-1458, issn 0009-7322, 4 p.Article

Statin Therapy—Part I: The Pleiotropic Effects of Statins in Cardiovascular DiseaseSADOWITZ, Benjamin; MAIER, Kristopher G; GAHTAN, Vivian et al.Vascular and endovascular surgery. 2010, Vol 44, Num 4, pp 241-251, issn 1538-5744, 11 p.Article

Physical Activity and Cardiovascular Disease Prevention : Current RecommendationsKOKKINOS, Peter.Angiology. 2008, Vol 59, issn 0003-3197, 28S-29S, SUP2Conference Paper

The Impact of Prevention on Reducing the Burden of Cardiovascular DiseaseKAHN, Richard; ROBERTSON, Rose Marie; SMITH, Robert et al.Circulation (New York, N.Y.). 2008, Vol 118, Num 5, pp 576-585, issn 0009-7322, 10 p.Article

Glucocorticoids and cardiovascular diseaseWALKER, Brian R.European journal of endocrinology. 2007, Vol 157, Num 5, pp 545-559, issn 0804-4643, 15 p.Article

Polyphénols et maladies cardiovasculairesBROUSTET, J.-P.Archives des maladies du coeur et des vaisseaux. Pratique. 2004, Num 134, pp 32-35, issn 1261-694X, 4 p.Conference Paper

Air pollution and cardiovascular diseaseFRANCHINI, Massimo; MANNUCCI, Pier Mannuccio.Thrombosis research. 2012, Vol 129, Num 3, pp 230-234, issn 0049-3848, 5 p.Conference Paper

Statin Therapy—Part II: Clinical Considerations for Cardiovascular DiseaseSADOWITZ, Benjamin; SEYMOUR, Keri; COSTANZA, Michael J et al.Vascular and endovascular surgery. 2010, Vol 44, Num 6, pp 421-433, issn 1538-5744, 13 p.Article

LDL-cholestérol et maladies cardiovasculairesBRUCKERT, E.Archives des maladies du coeur et des vaisseaux. Pratique. 2004, Num 134, pp 36-38, issn 1261-694X, 3 p.Article

Association between resting heart rate and arterial stiffness in Korean adultsPARK, Byoung-Jin; LEE, Hye-Ree; SHIM, Jae-Yong et al.Archives of cardiovascular diseases. 2010, Vol 103, Num 4, pp 246-252, issn 1875-2136, 7 p.Article

SPÉCIFICITÉS DU RISQUE CARDIOVASCULAIRE DE LA FEMME Les recommandations américainesMOUNIER-VEHIER, Claire; CLAISSE, Gonzague; KPOBEMABOU, Natalia et al.Cardiologie cardinale. 2012, Vol 6, Num 49, pp 156-160, issn 1960-1646, 5 p.Article

La variabilité glycémique: Quel impact sur le risque cardiovasculaire ?BONNET, Fabrice.Diabète & obésité. 2011, Vol 6, Num 49, pp 166-169, issn 1957-5238, 4 p.Article

Genomics in Cardiovascular DiseaseROBERTS, Robert; MARIAN, A. J; DANDONA, Sonny et al.Journal of the American College of Cardiology. 2013, Vol 61, Num 20, pp 2029-2037, issn 0735-1097, 9 p.Article

Sexual Activity and Cardiovascular Disease: A Scientific Statement From the American Heart AssociationLEVINE, Glenn N; STEINKE, Elaine E; TESSLER LINDAU, Stacy et al.Circulation (New York, N.Y.). 2012, Vol 125, Num 8, pp 1058-1072, issn 0009-7322, 15 p.Article

Prévart: accompagnement et suivi personnalisés : Réduction du risque cardiovasculaire des diabétiquesDUQUESNE, Ingrid; MOREL, Patricia; CRAPET, Bernadette et al.Concours médical (Paris). 2009, Vol 131, Num 13, issn 0010-5309, p. 492Article

Careers in Cardiovascular Disease Epidemiology and PreventionLUEPKER, Russell V.Circulation (New York, N.Y.). 2009, Vol 120, Num 6, pp 533-538, issn 0009-7322, 6 p.Article

Antioxidant Gene Therapy for Cardiovascular Disease : Current Status and Future PerspectivesLEVONEN, Anna-Liisa; VÄHÄKANGAS, Elisa; KOPONEN, Jonna K et al.Circulation (New York, N.Y.). 2008, Vol 117, Num 16, pp 2142-2150, issn 0009-7322, 9 p.Article

Measurement of Stiffness Index by Digital Volume Pulse Analysis Technique : Clinical Utility in Cardiovascular Disease Risk StratificationGUNARATHNE, Ashan; PATEL, Jeetesh V; HUGHES, Elizabeth A et al.American journal of hypertension. 2008, Vol 21, Num 8, pp 866-872, issn 0895-7061, 7 p.Article

Natriuretic Peptides : An Update on Bioactivity, Potential Therapeutic Use, and Implication in Cardiovascular DiseasesRU BATTU, Speranza; SCIARRETTA, Sebastiano; VALENTI, Valentina et al.American journal of hypertension. 2008, Vol 21, Num 7, pp 733-741, issn 0895-7061, 9 p.Article